Investor profile
FundPlus has backed 9 European tech companies across 12 funding rounds between 2021 and 2025, joining rounds totalling €742M. Most active in Healthtech. Data as of 6 Aug 2026.
Also recorded as: Fund plus
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Novadip Biosciences | Belgium | 2 | €59M |
| Coave Therapeutics | France | 2 | €53M |
| Minoryx Therapeutics |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Minoryx Therapeutics |
| Spain |
| 1 |
| €51M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| eTheRNA | Belgium | 1 | €39M |
| AstriVax | Belgium | 1 | €30M |
| Series C |
| €51M |
| 2022-05 |
| Novadip Biosciences | Series B | €40M | 2022-11 |
| eTheRNA | Series B | €39M | 2022-08 |
| TargED Biopharmaceuticals | Series A | €39M | 2022-02 |
| TargED Biopharmaceutical | Series A | €39M | 2022-02 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| AstriVax | Seed | €30M | 2022-08 |
